{
  "_id": "NCT00450047",
  "title": "Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia",
  "text": "Summary: The purpose of this study is to verify the efficacy of speed-feedback therapy in improving the cognitive function of elderly people with dementia by a randomized controlled trial, and to demonstrate how that affects ADL and QOL.\nInclusion criteria: inclusion criteria: \n\n 65 years of age or older \n\n Diagnosed with dementia by a physician \n\n Mini-Mental State Examination score of 23 points or less \n\n Capable of participating at least once a week for 6 weeks in succession \n\n \nExclusion criteria: : \n\n Management of a medical risk required \n\n Impaired ability to pedal the ergometer because of an orthopedic or surgical disease of the lower extremities or central nerve paralysis \n\n Never having been on a bicycle, and incapable of pedaling well",
  "metadata": {
    "brief_title": "Study on the Efficacy of Speed-Feedback Therapy for Elderly People With Dementia",
    "phase": "Phase 4",
    "drugs": "['Speed-feedback therapy system with a bicycle ergometer', 'Ergometer at conventional settings']",
    "drugs_list": [
      "Speed-feedback therapy system with a bicycle ergometer",
      "Ergometer at conventional settings"
    ],
    "diseases": "['Dementia']",
    "diseases_list": [
      "Dementia"
    ],
    "enrollment": "120.0",
    "inclusion_criteria": "inclusion criteria: \n\n 65 years of age or older \n\n Diagnosed with dementia by a physician \n\n Mini-Mental State Examination score of 23 points or less \n\n Capable of participating at least once a week for 6 weeks in succession \n\n ",
    "exclusion_criteria": ": \n\n Management of a medical risk required \n\n Impaired ability to pedal the ergometer because of an orthopedic or surgical disease of the lower extremities or central nerve paralysis \n\n Never having been on a bicycle, and incapable of pedaling well",
    "brief_summary": "The purpose of this study is to verify the efficacy of speed-feedback therapy in improving the cognitive function of elderly people with dementia by a randomized controlled trial, and to demonstrate how that affects ADL and QOL."
  }
}